1016/j
The Coronavirus Disease 2019 (COVID-19) pandemic is advancing globally, and pharmaceutical prophylaxis is one solution
16
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
3) o For non-hospitalized patients diagnosed with mild-to-moderate COVID-19 who are at high
32–0
Abstract
FDA Cautions against Use of Hydroxychloroquine or Chloroquine for COVID-19
The authors sought evidence of the effects of these drugs in treating people ill with the
President Trump took the malaria drug hydroxychloroquine as a preventative measure against Covid-19
In mice, a high dose of 90 mg/kg twice a day of CQ was necessary to achieve steady-state blood levels of 2
The media have featured the antimalarials chloroquine (CQ) and hydroxychloroquine (HCQ) to treat coronavirus (COVID-19)
It was quickly adopted in China, Europe, and the USA
Health care workers are at high risk of being infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
On August 4, 2020, the Centers for Disease Control and Prevention (CDC) reported over 121,000 cases of Covid-19 among healthcare personnel in the United States
In this review article, we have systematically searched for details of COVID-19 pandemic till May 2020 and assembled few data pertaining to (i) Corona viruses; (ii) SARS-CoV2, the virus that causes COVID-19’ and (iii) How chloroquine and hydroxychloroquine mediates anti-viral effect in both prophylactic and
For decades, chloroquine was a front-line drug for the treatment and prophylaxis of malaria and is one of the most prescribed drugs worldwide
The outbreak of coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global pandemic